Arizona Doctor Offers New Addiction Drug Treatment For Meth Addicts Showing More Than 60 Success Rate
With Arizona facing a critical crisis of methamphetamine use, Dr. Gregory Ellison, Director of Advanced Medical Center, has identified a very promising new addiction treatment option that shows high success rates and is performed on an out-patient (versus in-patient) basis in 10 hours over five sessions.
Spring Clean Your Diet
Ever thought of improving your eating habits as a spring cleaning job? Just as you give your house and garage a thorough once-over every year, you can do the same with your diet. Here's how.Clean it up. Drink more water and less soda drinks. "Drinks shouldn't be sticky, " says Pam Davis, R.
Arpida Provides Further Comments On The Pivotal Phase III Trials
Further to the press release published on 9 April, Arpida Ltd. (SWX: ARPN) elaborates on some additional elements of the clinical programme with intravenous iclaprim in complicated Skin and Skin Structure Infections (cSSSI). Extensive data on ASSIST-1 has been presented at last year's ICAAC and IDSA meetings.
Top 5 Ways To Protect Your Hearing
To celebrate Better Hearing and Speech Month, the House Ear Institute (HEI) is educating the public on noise-induced hearing loss (NIHL) with the top five ways to protect their hearing. An estimated 32.5 million people in the United States have a hearing loss.
Status Of The E2007 perampanel Development Program
E2007 (perampanel) is a first-in-class, orally administered, highly selective non-competitive AMPA-type glutamate receptor antagonist, in development by Eisai for several indications, including Parkinson's disease, neuropathic pain, epilepsy, multiple sclerosis and migraine prophylaxis.
MRI Best For Looking At Breast Cancer And More
The use of MRI is effective in differentiating the blood supply to medial and lateral breast tumors, which is important in treatment planning and prognosis according to a study conducted by researchers at the University of Miami in Miami, FL and the Rabin Medical Center in Petah Tikva, Israel.
EntreMed To Highlight ENMD-2076 Kinase Inhibitor At 2008 AACR Annual Meeting
EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced it will present preclinical data for its product candidates ENMD-2076, MKC-1, and ENMD-1198.
MDCT Accurate In Detecting Stenosis In Calcified Coronary Artery Plaque
Multidetector CT angiography can accurately predict the presence of obstructive disease (stenosis) in small and moderate-sized calcified coronary artery plaque (CAP), and is even fairly accurate in diagnosing large and heavily calcified CAP, according to a recent study conducted by researchers at Thomas Jefferson University Hospital in Philadelphia, PA.
Lung Transplants In Cystic Fibrosis Patients With Life Threatening Bacteria Sparks Debate At ISHLT Meeting
During Wednesday's Satellite Symposium 3: The Challenges of Lung Transplantation in Cystic Fibrosis (CF) at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, clinicians and researchers discussed some of the unique challenges in achieving excellent lung transplant outcomes in patients with CF.
PATHFAST R : Rapid Whole Blood Immunoassay Analyzer From Polymedco
Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer. The PATHFAST rapid point of care system utilizes a chemiluminescent technology combined with a unique magtration separation method that allows this system to report highly accurate results that compare to large platform instruments.